News Amgen Agrees to Deal to Buy Horizon Therapeutics – WSJ The U.S. biotechnology company will pay $116.50 for each Horizon share Amgen…Super UserDecember 12, 2022
News Emmes launches cell and gene therapy centre Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the…Super UserDecember 12, 2022
News Updated: Gilead, Arcellx team up on anti-BCMA CAR-T as biotech touts a 100% response rate at #ASH22 – Endpoints News Gilead and Kite are plunking down big cash to get into the…Super UserDecember 12, 2022
News Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma REDWOOD CITY, Calif., and SANTA MONICA, Calif., Dec. 9, 2022 /PRNewswire/ --…Super UserDecember 12, 2022
News Maryland Inno – Baltimore biotech Haystack Oncology raises $56M, plans move to City Garage The Johns Hopkins University researchers behind two of Baltimore's most successful biotech…Super UserDecember 9, 2022
News New UMD biotech campus to open in Montgomery County in 2023 The University of Maryland is partnering with Montgomery County to develop a…Super UserDecember 8, 2022
News Emmes Launches Cell and Gene Therapy Center Decades of Experience and Emerging Opportunities Led to its Creation ROCKVILLE, Md.,…Super UserDecember 8, 2022
News United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023 SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., December 08, 2022--(BUSINESS WIRE)--United…Super UserDecember 8, 2022
News Emergent BioSolutions Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for Over-the-Counter NARCAN® (naloxone HCl) Nasal Spray Emergent’s supplemental new drug application is the first prescription-to-over-the-counter switch application in…Super UserDecember 6, 2022
News DC Inno – Tech transfer program’s mission: Nurture tech-related businesses and retain “highly trained workforce” University of Maryland College Park (UMCP) graduates are some of the most…Super UserDecember 5, 2022